Literature DB >> 24487774

The role of diffusion-weighted MR imaging for differentiating benign from malignant bile duct strictures.

Hyun Jeong Park1, Seong Hyun Kim, Kyung Mi Jang, Seo-youn Choi, Soon Jin Lee, Dongil Choi.   

Abstract

OBJECTIVES: To assess the added value of diffusion-weighted imaging (DWI) to conventional magnetic resonance imaging (MRI) for differentiating benign from malignant bile duct strictures.
METHODS: Twenty-seven patients with a benign stricture and 42 patients with a malignant stricture who had undergone gadoxetic acid-enhanced MRI with DWI were enrolled. Qualitative (signal intensity, dynamic enhancement pattern) and quantitative (wall thickness and length) analyses were performed. Two observers independently reviewed a set of conventional MRI and a combined set of conventional MRI and DWI, and receiver operating characteristic (ROC) curve analysis was assessed.
RESULTS: Benign strictures showed isointensity (18.5-70.4 %) and a similar enhancement pattern (22.2 %) to that of normal bile duct more frequently than malignant strictures (0-40.5 % and 0 %) on conventional MRI (P < 0.05). Malignant strictures (90.5-92.9 %) showed hypervascularity on arterial and portal venous phase images more frequently than benign strictures (37.0-70.4 %) (P < 0.01) On DWI, all malignant strictures showed hyperintensity compared with benign cases (70.4 %) (P < 0.001). Malignant strictures were significantly thicker and longer than benign strictures (P < 0.001). The diagnostic performance of both observers improved significantly after additional review of DWI.
CONCLUSIONS: Adding DWI to conventional MRI is more helpful for differentiating benign from malignant bile duct strictures than conventional MRI alone. KEY POINTS: • Accurate diagnosis and exclusion of benign strictures of bile duct are important. • Diffusion-weighted MRI helps to distinguish benign from malignant bile duct strictures. • DWI plus conventional MRI provides superior diagnostic accuracy to conventional MRI alone.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24487774     DOI: 10.1007/s00330-014-3097-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  22 in total

1.  Immunoglobulin G4-associated sclerosing cholangitis mimicking cholangiocarcinoma.

Authors:  D T M Chung; C N Tang; E C H Lai; G P C Yang; M K W Li
Journal:  Hong Kong Med J       Date:  2010-04       Impact factor: 2.227

Review 2.  Diffusion-weighted MR imaging of the liver.

Authors:  Bachir Taouli; Dow-Mu Koh
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

3.  Recurrent pyogenic cholangitis: comparison between MR cholangiography and direct cholangiography.

Authors:  M S Park; J S Yu; K W Kim; M J Kim; J P Chung; S W Yoon; J J Chung; J T Lee; H S Yoo
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

4.  Biliary tract involvement in autoimmune pancreatitis.

Authors:  Takayoshi Nishino; Fumitake Toki; Hiroyasu Oyama; Itaru Oi; Makio Kobayashi; Ken Takasaki; Keiko Shiratori
Journal:  Pancreas       Date:  2005-01       Impact factor: 3.327

5.  Half-Fourier RARE MR cholangiopancreatography: experience in 300 subjects.

Authors:  A S Fulcher; M A Turner; G W Capps; A M Zfass; K M Baker
Journal:  Radiology       Date:  1998-04       Impact factor: 11.105

6.  Cholangiocarcinoma: delayed CT contrast enhancement patterns.

Authors:  J M Lacomis; R L Baron; J H Oliver; M A Nalesnik; M P Federle
Journal:  Radiology       Date:  1997-04       Impact factor: 11.105

7.  CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis.

Authors:  Hee Sun Park; Jeong Min Lee; Se Hyung Kim; Jun Yong Jeong; Young Jun Kim; Kyoung Ho Lee; Seung Hong Choi; Joon Koo Han; Byung Ihn Choi
Journal:  AJR Am J Roentgenol       Date:  2006-08       Impact factor: 3.959

8.  Cholangiocarcinoma: spectrum of appearances on MR images using current techniques.

Authors:  S Worawattanakul; R C Semelka; T C Noone; B F Calvo; N L Kelekis; J T Woosley
Journal:  Magn Reson Imaging       Date:  1998-11       Impact factor: 2.546

9.  Autoimmune cholangitis mimicking periductal-infiltrating cholangiocarcinoma.

Authors:  Ko Woon Park; Jae Hoon Lim; Kee Taek Jang; Dong Wook Choi
Journal:  Abdom Imaging       Date:  2008 May-Jun

10.  Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.

Authors:  Tejas Parikh; Stephen J Drew; Vivian S Lee; Samson Wong; Elizabeth M Hecht; James S Babb; Bachir Taouli
Journal:  Radiology       Date:  2008-01-25       Impact factor: 11.105

View more
  6 in total

Review 1.  Multimodality imaging of intrahepatic cholangiocarcinoma.

Authors:  Kelly Fábrega-Foster; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

2.  [Radiologic diagnostics of the gall bladder and bile ducts-part 1 : Imaging techniques-normal variants and congenital disorders-cholelithiasis].

Authors:  H Helmberger; B Kammer
Journal:  Radiologe       Date:  2018-11       Impact factor: 0.635

Review 3.  Evaluation of indeterminate biliary strictures.

Authors:  Christopher L Bowlus; Kristin A Olson; M Eric Gershwin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-11-03       Impact factor: 46.802

4.  Added value of diffusion-weighted imaging in hepatic tumors and its impact on patient management.

Authors:  Jana Taron; Jonas Johannink; Michael Bitzer; Konstantin Nikolaou; Mike Notohamiprodjo; Rüdiger Hoffmann
Journal:  Cancer Imaging       Date:  2018-03-07       Impact factor: 3.909

Review 5.  Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology.

Authors:  Dong Ho Lee; Bohyun Kim; Eun Sun Lee; Hyoung Jung Kim; Ji Hye Min; Jeong Min Lee; Moon Hyung Choi; Nieun Seo; Sang Hyun Choi; Seong Hyun Kim; Seung Soo Lee; Yang Shin Park; Yong Eun Chung
Journal:  Korean J Radiol       Date:  2020-08-28       Impact factor: 3.500

Review 6.  [Current Status and Recent Update of Imaging Evaluation for Peri-Hilar Cholangiocarcinoma].

Authors:  Dong Ho Lee
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.